Nanoscience Technologies, Inc. Appoints David Keenan To President And Chief Executive Officer
10/19/2005 5:12:55 PM
NEW YORK--(BUSINESS WIRE)--Sept. 27, 2005--Nanoscience Technologies, Inc. (OTCBB:NANS) announced the appointment of David Keenan, 49, to President and CEO. In his new role with the Company Mr. Keenan will assume responsibility for all operating venues and focus on developing corporate research & development partnerships and identifying licensing opportunities for the area of DNA nanotechnology. NTI holds the worldwide exclusive licensing rights to the intellectual property of Dr. Nadrian Seeman, Professor of Chemistry at New York University.
comments powered by